Skip to content

Clinical trials

Phase 3 Ventricular Dysfunction, Left trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ventricular Dysfunction, Left Phase: Phase 3 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20111
20121
20141
20151
20161
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Aspirus Heart and Vascular Institute-Research and Education1
Baylor Research Institute1
BioControl Medical1
Cardiovascular Clinical Sciences Inc1
Cedars-Sinai Medical Center1
Mesoblast, Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ventricular Dysfunction, Left9
Heart Failure3
Death, Sudden, Cardiac1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Inflammation1
Non-ST Elevated Myocardial Infarction1
Renal Insufficiency, Chronic1
ST Elevation Myocardial Infarction1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.